10/16 MannKind - Script Sales Dip To Start Q4 •Script sales of Afrezza dip to just above 400. •Potential cash infusion via dilution could allow for a slightly bigger marketing budget. •Cash issue not as critical, but also not resolved. https://seekingalpha.com/article/4113677-mannkind-script-sales-dip-start-q4?auth_param=1vat:1cu9dc2:3aff7ff71fb7182d21b2153df1e3269f&uprof=51